The Hans Prydz Lecture Series is a series of guest lectures open for all:
This lecture series of distinguished international speakers organized jointly by the Biotechnology Centre of Oslo and Centre for Molecular Medicine Norway is named after Hans Prydz.
Kimberley Dodge-Kafka, Associate Professor at the Department of Cell Biology at the University of Connecticut, will give a lecture titled, "mAKAP- a master regulator of cardiac hypertrophy"
Howard Young from the Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada will give a lecture titled, 'Correlating Structure and Function of Human Genetic Variants in Calcium Homeostasis and Cardiac Contractility'
Imre Västrik, Research Coordinator in the Bioinformatics Team at the Institute for Molecular Medicine Finland (FIMM) will give a talk titled, "TheDB - a smart integrated IT systemfor managing and analysing precision medicine data"
Dr. Eivind Valen, Group Leader at the Computational Biology Unit of the University of Bergen, will present the lecture "Searching for function in the dark matter of the genome."
IOB hosts a mini-seminar on molecular changes in aging with two invited speakers from the Center for Healthy Aging at the University of Copenhagen.
Welcome to the next Oslo University Hospital (OUH) Research Seminar: "Individualised Cancer Treatment"
Michail Sitkovsky, Professor and Director of the New England Inflammation and Tissue Protection Institute at the Northeastern University College of Science, Boston, USA, will give a guest lecture titled, 'Anti-Hypoxia/HIF-1alpha and anti-A2A-Adenosinergic Co-adjuvants to enable the rejection of the most therapy-resistant tumors'
Dr. Christopher Yau, Reader in Computational Biology based in the Centre for Computational Biology at the University of Birmingham will give a lecture titled, "Probabilistic modelling approach for pseudotime estimation in single cells and populations."
Lecture "A new era of medicine with induced pluripotent stem cells – iPS cells" and panel discussion "Implications of Stem Cell Therapy for Patients and Society" with Shinya Yamanaka, 2012 Nobel Laureate in Physiology or Medicine.
'Exploring and exploiting the constraints of local signaling', by Professor John D. Scott
Morten Schak Nielsen, of Copenhagen University, will give a lecture titled, 'Connexin 43 gap junctions at the nexus of cardiac activation'.
Second in the Sven Furberg Seminar Series: Dr. Robin Andersson, Assistant Professor, University of Copenhagen, Denmark, will present the lecture, "Characterisation of regulatory activities and active chromatin architectures from transcription initiation events."
Professor Steve Bova is a Professor and Group Leader at the Prostate Cancer Research Center, Institute of Biosciences and Medical Technology, BioMediTech, University of Tampere and Fimlab Laboratories, Tampere University Hospital in Finland.
He will give a talk titled, 'Leveraging the evolutionary history of metastatic prostate cancer'.
Jaime Castro-Mondragòn is a PhD student in Bioinformatics. The title of his talk is, 'Identification of Transcription Factors related to mammalian promoters with distal functions'.
Dr. Harald Binder, Professor, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University Mainz, Germany, will present the lecture:
"Two uses of stagewise regression: from landmarking in cancer patients to deep learning for SNPs".
Hesso Farhan is an Associate Professor at the Institute of Basic Medical Sciences in Oslo. His group is interested in investigating the link between signal transduction and the endomembrane system. The group uses a combination of classical molecular cell biology techniques, system biology and mathematical modeling to understand the spatial-temporal regulation of signaling pathways and its role in the orchestrating fundamental cellular processes such as secretion, cell migration, polarity, and growth.
The title of the talk is: Organization of Cellular Signaling in Time and Space: Relevance for Growth and Migration of Cancer Cells.
Pia Abel zur Wiesch at the Institute of Pharmacy, UiT The Arctic University of Norway is heading the Systems Pharmacology group that uses theoretical models in close collaboration with experimentalists and clinicians to explore how we could use both within-host and population-wide drug treatment strategies to minimize human morbidity and mortality. The group is focusing on bacterial population dynamics, specifically pathogen population dynamics of anti-infective therapy. Pia Abel zur Wiesch in addition holds a visiting professorship at Yale School of Public Health. The title of her talk is "How to design drug dosing strategies: at the interface of chemical kinetics and population biology".
Ph.D. Kirsi Ketola has trained in systems biology and medical biotechnology as well as in biochemistry and drug discovery. The title of her talk is 'Tumour cell plasticity and cancer stem cell - neuroendocrine transdifferentiation as a resistance mechanism and therapeutic target in advanced prostate cancer'.
Trude H. Flo is heading a research group on host-pathogen interactions in mycobacterial and HIV infection. The title of her talk is “'The inner life of a Mycobacterium avium infected macrophage”.
The Sandberg group is interested in the immunology and immunopathogenesis of viral infectious diseases. Professor Sandberg’s talk is entitled “Role of MAIT cells in health and viral infectious disease”.
Dr. Whiteside’s research expertise is in cellular and molecular cancer immunology. She works with various subsets of human immune cells and studies their functional impairments in patients with cancer.
Professor Tobias Bopp is a Professor at Institute for immunology at University Medical Center of the Johannes Gutenberg-University Mainz and works with mice that are double-deficient in the transcription factors NFATc2 and NFATc3.
NOR-openscreen is the Norwegian node of the EU-OPENSCREEN infrastructure project. We support the discovery of biologically active substances in all areas of the Life Sciences by providing transnational, open access to the most advanced technologies, chemical and biological resources as well as expertise through Europe.